Hyperthermic isolated perfusion using cisplatin for treatment of the extremities.
Takeyama
S
S
Tateishi
A
A
Higaki
S
S
Yamanashi
M
M
D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D001859:Bone Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D010478:Chemotherapy, Cancer, Regional Perfusion; D002648:Child; D002945:Cisplatin / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D005266:Femoral Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery / Q000628:therapy; D005360:Fibula / Q000601:surgery; D005500:Follow-Up Studies; D006801:Humans; D006979:Hyperthermia, Induced; D007261:Infusions, Intra-Arterial; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D009336:Necrosis; D012516:Osteosarcoma / Q000188:drug therapy / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D013977:Tibia / Q000601:surgery; D014018:Tissue Distribution; D016896:Treatment Outcome
D004317:Doxorubicin; D002945:Cisplatin; D008727:Methotrexate